Page last updated: 2024-08-24

motapizone and roflumilast

motapizone has been researched along with roflumilast in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hatzelmann, A; Schudt, C	1

Other Studies

1 other study(ies) available for motapizone and roflumilast

Article	Year
Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:1 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; CD4-Positive T-Lymphocytes; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Cytokines; Dendritic Cells; Eosinophils; Humans; Immunosuppressive Agents; In Vitro Techniques; Luminescent Measurements; Lymphocyte Activation; Monocytes; Neutrophils; Phosphodiesterase Inhibitors; Pyridazines; Tumor Necrosis Factor-alpha	2001

Article

Year

Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro.

The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:1

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; CD4-Positive T-Lymphocytes; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Cytokines; Dendritic Cells; Eosinophils; Humans; Immunosuppressive Agents; In Vitro Techniques; Luminescent Measurements; Lymphocyte Activation; Monocytes; Neutrophils; Phosphodiesterase Inhibitors; Pyridazines; Tumor Necrosis Factor-alpha

2001